Ledger.Open graph →
SEC Form D · filed July 7, 2023

IGM Biosciences, Inc

Offering
$22.5M
Sold
$22.5M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
MOUNTAIN VIEW, CA
Type

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (28)

Fred M. Schwarzer · Mountain View, CAExec · DirectorM. Kathleen J. Behrens · Mountain View, CADirectorJulie J. Hambleton · Mountain View, CADirectorChristina T. Topsoe · Mountain View, CADirectorFelix J. Baker · LEXINGTON, MADirectorGeorge A. Gauthier · Mountain View, CAExecMisbah A. Tahir · Mountain View, CAExecLisa L. Decker · Mountain View, CAExecMichael J. Loberg · Mountain View, CADirectorWilliam J. Strohl · Mountain View, CADirectorBruce A. Keyt · Mountain View, CAExecChris H. Takimoto · Mountain View, CAExecJakob H. Topsoe · Kongens Lyngby, NetherlandsDirectorMichael J. Lee · Santa Rosa, CADirectorFelix J. Baker · Mountain View, CADirectorGeorge A. Gauthier · Mountain View, CAExecFred M. Schwarzer · Mountain View, CAExec · DirectorMisbah A. Tahir · Mountain View, CAExecLisa L. Decker · Mountain View, CAExecMichael J. Loberg · Mountain View, CADirectorWilliam J. Strohl · Mountain View, CADirectorBruce A. Keyt · Mountain View, CAExecM. Kathleen J. Behrens · Mountain View, CADirectorJulie J. Hambleton · Mountain View, CADirectorChris H. Takimoto · Mountain View, CAExecJakob H. Topsoe · Kongens Lyngby, NetherlandsDirectorChristina T. Topsoe · Mountain View, CADirectorMichael J. Lee · NORTH HOLLYWOOD, CADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗